BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 31541597)

  • 1. Evaluation of combined excimer laser and platelet-rich plasma for the treatment of nonsegmental vitiligo: A prospective comparative study.
    Khattab FM; Abdelbary E; Fawzi M
    J Cosmet Dermatol; 2020 Apr; 19(4):869-877. PubMed ID: 31541597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined treatment with fractional carbon dioxide laser, autologous platelet-rich plasma, and narrow band ultraviolet B for vitiligo in different body sites: A prospective, randomized comparative trial.
    Abdelghani R; Ahmed NA; Darwish HM
    J Cosmet Dermatol; 2018 Jun; 17(3):365-372. PubMed ID: 28834191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between 308-nm excimer light alone versus 308-nm excimer light and platelet-rich plasma in the treatment for localized vitiligo.
    Elsaadany AE; El-Khalawany M; Elshahid AR; Seddeik Abdel-Hameed AK
    J Cosmet Dermatol; 2022 Jul; 21(7):2826-2831. PubMed ID: 34719101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monochromatic excimer light versus combination of topical steroid with vitamin D3 analogue in the treatment of nonsegmental vitiligo: a randomized blinded comparative study.
    Abdel Latif AA; Ibrahim SM
    Dermatol Ther; 2015; 28(6):383-9. PubMed ID: 26358764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current art of combination therapy with autologous platelet-rich plasma for stable vitiligo: A meta-analysis.
    Chen J; Wan Y; Lin Y; Jiang H
    Int Wound J; 2021 Jun; 18(3):251-260. PubMed ID: 33245822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of the efficacy of adding platelet-rich plasma to 308-nm excimer laser for patients with vitiligo.
    Chen J; Yu N; Li H; Tang Y; Zhu H
    J Int Med Res; 2022 Sep; 50(9):3000605221119646. PubMed ID: 36062405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 308-nm Excimer Laser Plus Platelet-Rich Plasma for Treatment of Stable Vitiligo: A Prospective, Randomized Case-Control Study.
    Deng Y; Li J; Yang G
    Clin Cosmet Investig Dermatol; 2020; 13():461-467. PubMed ID: 32801821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of clinical efficacy and psychosocial impact on vitiligo patients by excimer laser treatment.
    Al-Shobaili HA
    Ann Saudi Med; 2014; 34(2):115-21. PubMed ID: 24894779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Safety of 308-nm Monochromatic Excimer Lamp Versus Other Phototherapy Devices for Vitiligo: A Systematic Review with Meta-Analysis.
    Lopes C; Trevisani VF; Melnik T
    Am J Clin Dermatol; 2016 Feb; 17(1):23-32. PubMed ID: 26520641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of fractional erbium-YAG laser, microneedling, platelet-rich plasma in localized stable vitiligo patients: randomized clinical trial.
    Abdel-Hamid S; Ibrahim HM; Hameed AM; Hegazy EM
    Arch Dermatol Res; 2024 Jun; 316(7):399. PubMed ID: 38878236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Narrowband ultraviolet B phototherapy combined with intralesional injection of either latanoprost or platelet-rich plasma for stable nonsegmental vitiligo.
    Fawzy M; Al-Mokadem S; Alshereef M; Elkholy B
    Photodermatol Photoimmunol Photomed; 2024 Jan; 40(1):e12929. PubMed ID: 37984828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study between excimer light and topical antioxidant versus excimer light alone for treatment of vitiligo.
    Soliman M; Samy NA; Abo Eittah M; Hegazy M
    J Cosmet Laser Ther; 2016; 18(1):7-11. PubMed ID: 26052813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of excimer laser treatment on vitiliginous areas with leukotrichia after confirmation by dermoscopy.
    Kim MS; Cho EB; Park EJ; Kim KH; Kim KJ
    Int J Dermatol; 2016 Aug; 55(8):886-92. PubMed ID: 26498729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo.
    Passeron T; Ostovari N; Zakaria W; Fontas E; Larrouy JC; Lacour JP; Ortonne JP
    Arch Dermatol; 2004 Sep; 140(9):1065-9. PubMed ID: 15381545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A preliminary study of fractional CO
    Wen X; Hamblin MR; Xian Y; Li Y
    Dermatol Ther; 2019 Jan; 32(1):e12747. PubMed ID: 30238584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study between efficacy of Excimer light with topical Tacrolimus 0.1% versus excimer light with topical Bimatoprost 0.01% in treatment of facial Vitiligo.
    Zaky MS; Atallah RB; El Abasy NTA; Elsaie ML
    Arch Dermatol Res; 2024 Jun; 316(7):350. PubMed ID: 38850408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicentre, randomized, split face and/or neck comparison of 308-nm excimer laser and 0ยท1% tacrolimus ointment for stable vitiligo plus intramuscular slow-releasing betamethasone for active vitiligo.
    Wu Y; Sun Y; Qiu L; Wang H; Zhang Y; Chen K; Li H; Gu H; Zhang J; Gao XH
    Br J Dermatol; 2019 Jul; 181(1):210-211. PubMed ID: 30644997
    [No Abstract]   [Full Text] [Related]  

  • 18. Pilot Study on the Use of the "Monocyte-Rich" Platelet-Rich Plasma in Combination with 1927 nm Fractional and 308 nm Excimer Lasers for the Treatment of Vitiligo.
    Mercuri SR; Di Nicola MR; Brianti P; Bianchi VG; Paolino G
    Medicina (Kaunas); 2021 Aug; 57(9):. PubMed ID: 34577827
    [No Abstract]   [Full Text] [Related]  

  • 19. A review of monochromatic excimer light in vitiligo.
    Park KK; Liao W; Murase JE
    Br J Dermatol; 2012 Sep; 167(3):468-78. PubMed ID: 22524428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of platelet-rich plasma on the outcome of short-term narrowband-ultraviolet B phototherapy in the treatment of vitiligo: a pilot study.
    Ibrahim ZA; El-Ashmawy AA; El-Tatawy RA; Sallam FA
    J Cosmet Dermatol; 2016 Jun; 15(2):108-16. PubMed ID: 26695436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.